Showing results (201-210 of 319) with videos related to
Sort By:
Pageof 32
Clinical Lymphoma, Myeloma & Leukemia|November 8, 2025
Perspectives on Anti-BCMA Bispecific Antibodies use in Multiple Myeloma-Experience from Asian CountriesCinnie Soekojo, Shimin Jasmine Chung, Ming-Tao Tsai, et al.Haematologica|October 15, 2020
ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemiaJianbiao Zhou, Jessie Yiying Quah, Yvonne Ng, et al.Clinical Lymphoma, Myeloma & Leukemia|June 15, 2026
Pharmacokinetics and Safety of Belantamab Mafodotin Monotherapy in Patients With Relapsed/Refractory Multiple Myeloma Who Have Normal and Varying Degrees of Impaired Renal FunctionXi Chen, Shawn Hakim, Yi Ting Kayla Lien, et al.Plos One|May 19, 2011
PRL-3, a metastasis associated tyrosine phosphatase, is involved in FLT3-ITD signaling and implicated in anti-AML therapyJianbiao Zhou, Chonglei Bi, Wee-Joo Chng, et al.Cancer Research|July 18, 2023
Histone Methyltransferase NSD2 Activates PKCα to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple MyelomaPhyllis S Y Chong, Jing-Yuan Chooi, Julia S L Lim, et al.Cytometry. Part B, Clinical Cytometry|April 22, 2017
The utility of flow cytometry in differentiating NK/T cell lymphoma from indolent and reactive NK cell proliferationsSanjay de Mel, Jenny Bei Li, Muhammad Bilal Abid, et al.Journal of Hematology & Oncology|September 5, 2015
Pharmacokinetics and safety of ixazomib plus lenalidomide-dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 studyNeeraj Gupta, Yeow Tee Goh, Chang-Ki Min, et al.Science Translational Medicine|August 10, 2018
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP)Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, et al.Clinical Hematology International|April 24, 2025
Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working GroupWenming Chen, Zhen Cai, James Cs Chim, et al.Journal of Neurosurgery|November 4, 2008
Characterization of a side population of astrocytoma cells in response to temozolomideConstance Chua, Norazean Zaiden, Kooi-Hoong Chong, et al.Pageof 32